Clinical Trial Update: MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports on the MILES-02 study evaluating chemotherapy treatment and toxicity in elderly patients with advanced non-small cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED